2022 Ljubljana, Slovenia

II-40 Qing Xi Ooi
Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity
Wednesday 15:10-16:40